Jane Street Group, LLC Lixte Biotechnology Holdings, Inc. Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.12 - $5.9 $294 - $14,496
2,457 Added 19.14%
15,293 $9,000
Q2 2022

Aug 16, 2022
SELL
$0.12 - $0.35 $833 - $2,431
-6,948 Reduced 35.12%
12,836 $10,000
Q1 2022

May 17, 2022
BUY
$0.16 - $0.35 $3,165 - $6,924
19,784 New
19,784 $24,000

About LIXTE BIOTECHNOLOGY HOLDINGS, INC.

LIXT Quotes by TradingView
  • Ticker LIXT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,646,600
  • Market Cap $33.6M
  • Description
  • Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agent...
More about LIXT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email